T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study.

MLA

Angyal, Adrienn, et al. “T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously Infected and SARS-CoV-2-Naive UK Health-Care Workers: A Multicentre Prospective Cohort Study.” The Lancet. Microbe, vol. 3, no. 1, Jan. 2022, pp. e21–31. EBSCOhost, https://doi.org/10.1016/S2666-5247(21)00275-5.

APA

Angyal, A., Longet, S., Moore, S. C., Payne, R. P., Harding, A., Tipton, T., Rongkard, P., Ali, M., Hering, L. M., Meardon, N., Austin, J., Brown, R., Skelly, D., Gillson, N., Dobson, S. L., Cross, A., Sandhar, G., Kilby, J. A., Tyerman, J. K., … de Silva, T. I. (2022). T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. The Lancet. Microbe, 3(1), e21–e31. https://doi.org/10.1016/S2666-5247(21)00275-5

Chicago

Angyal, Adrienn, Stephanie Longet, Shona C Moore, Rebecca P Payne, Adam Harding, Tom Tipton, Patpong Rongkard, et al. 2022. “T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously Infected and SARS-CoV-2-Naive UK Health-Care Workers: A Multicentre Prospective Cohort Study.” The Lancet. Microbe 3 (1): e21–31. doi:10.1016/S2666-5247(21)00275-5.